INVO Fertility Inc
NASDAQ:IVF

Watchlist Manager
INVO Fertility Inc Logo
INVO Fertility Inc
NASDAQ:IVF
Watchlist
Price: 0.9002 USD -10.87% Market Closed
Market Cap: 1.7m USD

INVO Fertility Inc
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

INVO Fertility Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
INVO Fertility Inc
NASDAQ:IVF
Operating Income
-$9.2m
CAGR 3-Years
-7%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Operating Income
$3.5B
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Operating Income
$3.8B
CAGR 3-Years
24%
CAGR 5-Years
29%
CAGR 10-Years
15%
Stryker Corp
NYSE:SYK
Operating Income
$5.4B
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Operating Income
$8B
CAGR 3-Years
-6%
CAGR 5-Years
13%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$2.8B
CAGR 3-Years
19%
CAGR 5-Years
22%
CAGR 10-Years
15%
No Stocks Found

INVO Fertility Inc
Glance View

Market Cap
1.7m USD
Industry
Health Care

INVO Fertility Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Sarasota, Florida and currently employs 25 full-time employees. The company went IPO on 2008-11-11. INVO Fertility Inc., formerly NAYA Biosciences, Inc., is a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition, and operation of fertility clinics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution into third-party owned and operated fertility clinics. The INVOcell is a proprietary medical device that allow fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.

IVF Intrinsic Value
Not Available

See Also

What is INVO Fertility Inc's Operating Income?
Operating Income
-9.2m USD

Based on the financial report for Sep 30, 2025, INVO Fertility Inc's Operating Income amounts to -9.2m USD.

What is INVO Fertility Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-15%

Over the last year, the Operating Income growth was -62%. The average annual Operating Income growth rates for INVO Fertility Inc have been -7% over the past three years , -15% over the past five years .

Back to Top